Assessment of Inflammatory Back Pain: New Concepts in Diagnosis

Similar documents
Axial Spondyloarthritis. Doug White, Rheumatologist Waikato Hospital

37 year old male with several year history of back pain


What is Axial Spondyloarthritis?

The Complex/Challenging Spine Patient Steve Wisniewski, M.D. Department of PM&R

Dr Tracey Kain. Associate Professor Ed Gane

SpA non-radiografica: fase precoce di spondilite anchilosante o altro?

Juvenile Spondyloarthritis / Enthesitis Related Arthritis (SpA-ERA)

Concept of Spondyloarthritis (SpA)

ESPONDILOARTROPATÍAS. Dr. Julio Ramírez García

CLOSER LOOK AT SpA. Dr. Mohamed Bedaiwi. Consultant Rheumatologist Rheumatology Unit - KKUH

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE. Proposed Health Technology Appraisal

Why is this important for you? Types of arthritis. Information for the public Published: 28 February 2017 nice.org.uk

Differentiating Inflammatory and Mechanical Back Pain

Identification of Psoriatic Arthritis and Ankylosing Spondylitis Early Detection to Facilitate Appropriate Care

New developments in the diagnosis and treatment of axial spondyloarthritis

Do HLA-B27 positive patients differ from HLA-B27 negative patients in clinical presentation

8/29/2012. Outline Juvenile idiopathic arthritis. 1. Classification-ILAR. 1. Classification-clinical diagnosis. 1. JIA classification

Chapter 2. Overview of ankylosing spondylitis

Juvenile Spondyloarthritis / Enthesitis Related Arthritis (SpA-ERA)

Evaluation of multiple referral strategies for axial spondyloarthritis in the SPondyloArthritis Caught Early (SPACE) cohort

Low Back Pain - Inflammatory and Mechanical pdf 5 th Oct 2016

Assessing the Signs, Symptoms, and Clinical Manifestations of Axial SpA

Assessing the Signs, Symptoms, and Clinical Manifestations of Axial SpA

First Presentation of Joint Pain

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP)

Guideline on the Clinical Investigation of Medicinal Products for the Treatment of Axial Spondyloarthritis

Gender differences in effectiveness of treatment in rheumatic diseases

Axial Spondyloarthritis: Issues & Controversies

10/28/2013. Disclosure. Ustekinumab. IL-12, IL-23 and Ustekinumab. IL-23 in Facet Joints in Patients with AS

Seronegative Spondyloarthropathies (SpA)

Seronegative Arthritis. Dr Mary Gayed 25 th April 2018

Spondyloarthritis: Practice. New Concepts in. Epidemiology and Clinical

DIFFERENTIATING INFLAMMATORY AND MECHANICAL BACK PAIN

Rheumatoid Arthritis. Marge Beckman FALU, FLMI Vice President RGA Underwriting Quarterly Underwriting Meeting March 24, 2011

axial spondyloarthritis including ankylosing spondylitis

Mary Derlacki, FNP. No financial relationships to disclose. Office Rheumatology for the Nurse Practitioner. Rheumatoid Arthritis

Introduction. Natural Progression of AS. Sacroiliac Joint. Clinical Features and Assessment of Ankylosing Spondylitis

A Patient s Guide to Spondyloarthropathies

5/4/2018. Outcome Measures in Spondyloarthritis. Learning Objectives. Outcome Measures Clinical Outcome Assessments

Update - Imaging of the Spondyloarthropathies. Spondyloarthropathies. Spondyloarthropathies

JUVENILE SPONDYLOARTHROPATHIES

Missed, Misdiagnosed & Mistreated: De-Mystifying Three Common Rheumatic Diseases

ABSTRACT ORIGINAL RESEARCH. Laure Tant. Nadine Delmotte. Maria Van den Enden. Valerie Gangji. Herman Mielants

Rheumatology Subcommittee of PTAC Meeting held 7 October (minutes for web publishing)

Imaging of axial spondyloarthritis including ankylosing spondylitis

Spondylarthropathies. Outline. Introduction. Spondylarthropathy other than AS. Mimickers of spondylarthropathy. Conclusions.

6/6/2017. Spondyloarthritis and Osteopathic Primary Care: Facts and Challenges. Progression of Ankylosing Spondylitis Classic Disease

Juvenile Idiopathic Arthritis (JIA)

May 29, An interprofessional approach to back pain assessment and rehabilitation Musculoskeletal Conference

2004 Health Press Ltd.

adalimumab, 40mg/0.8mL, solution for injection (Humira ) SMC No. (858/13) AbbVie Ltd (previously part of Abbott)

Serum sclerostin as a possible biomarker in ankylosing spondylitis: a casecontrol

ARTHRITIS ADVISORY COMMITTEE MEETING

ANKYLOSING SPONDYLITIS (AS)

Multiple Technology Appraisal (MTA)

EXAMINING THE CRUCIAL COALITION BETWEEN DERMATOLOGY AND RHEUMATOLOGY IN PSORIATIC ARTHRITIS

ARTHRITIS ADVISORY COMMITTEE MEETING

Anti-CD74 antibodies have no diagnostic value in early axial spondyloarthritis: data from the spondyloarthritis caught early (SPACE) cohort

Systematic review and analysis of evidences on clinical efficacy and cost-effectiveness of biological drugs for the treatment of

Are gender-specific approaches needed in diagnosing early axial spondyloarthritis? Data from the SPondyloArthritis Caught Early cohort

Current Concept of Spondyloarthritis: Special Emphasis on Early Referral and Diagnosis

Golimumab, compared to placebo, significantly improved symptoms in adults with active nonradiographic

A Patient s Guide to Psoriatic Arthritis

Objectives. Joint Pain. Case 1. Rheumatology for the Primary MD (Not just your grandmother s disease) 12/4/2010

Clinical and spinal radiographic outcome in axial spondyloarthritis Maas, Fiona

Nonradiographic axial spondyloarthritis: clinical and therapeutic relevance

Diagnostic Value and Validity of Early Spondyloarthritis Features: Results From a National Spanish Cohort

Imaging and intervention of sacroiliac joint. Dr Ryan Lee Ka Lok Associate Consultant Prince of Wales Hospital

Heel pain in spondyloarthritis: results of a cross-sectional study of 275 patients

Etiology: Pathogenesis Clinical manifestation Investigation Treatment Prognosis

Do extra-articular manifestations influence outcome in ankylosing spondylitis? 12-year results from OASIS

Concept of Spondyloarthritis (SpA)

2014 Update on the CRA/SPARCC Treatment Recommendations for the Management of Spondyloarthritis

9 Lecture. Spondyloarthropathy แพทย หญ งน นทนา กส ตานนท คณะแพทยศาสตร มหาว ทยาล ยเช ยงใหม

SPONDYLOARTHRITIS: PATHOGENESIS, CLINICAL MANIFESTATIONS, DIAGNOSIS, AND MANAGEMENT

Pulmonary Manifestations of Ankylosing Spondylitis

Clinical Policy: Certolizumab (Cimzia) Reference Number: PA.CP.PHAR.247 Effective Date: 01/18 Last Review Date: 08/17 Line of Business: Medicaid

BRIEF REPORT. Denis Poddubnyy, 1 Hildrun Haibel, 1 J urgen Braun, 2 Martin Rudwaleit, 3 and Joachim Sieper 1

NIH Public Access Author Manuscript Curr Opin Rheumatol. Author manuscript; available in PMC 2011 January 20.

Ankylosing Spondylitis. DR. Milt Baker SEA Courses 2017

Ad-Hoc Rheumatology Subcommittee of PTAC meeting held 8 March. (minutes for web publishing)

Department of Radiology, Aarhus University Hospital, Aarhus, Denmark; 4. Key words MRI, sacroiliitis, ankylosing spondylitis, axial spondyloarthritis.

I J Sørensen,15 R Valle-Oñate,16 U Weber,17 J Wei,18 J Sieper,1,19

ARD Online First, published on October 11, 2005 as /ard

Characterization of Patients With Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis in the US-Based Corrona Registry

SPARTAN NEWS. Greetings!

Chapter 2 Criteria and Disease Activity Measures in Axial Spondyloarthropathies

APPLICATION FOR SUBSIDY BY SPECIAL AUTHORITY

Hello, I m Christopher Ritchlin, from the University of Rochester Medical Center, and I have the pleasure today of discussing with you abstracts

Ankylosing Spondylitis: Overarching Concerns New Concepts and New Treatment for Spondyloarthritis

Overview of axial spondyloarthritis

Rheumatologic Manifestations of Gastrointestinal Diseases

Rheumatoid Arthritis. Rheumatoid Arthritis. RCS 6080 Medical and Psychosocial Aspects of Rehabilitation Counseling. Rheumatic Diseases

FIBROMYALGIA ANNE WINKLER MD PHD MO ACP MEETING SEPT 2016

PREVALENCE OF SPONDYLOARTHROPATHY IN PUERTO RICAN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Department of Paediatrics Clinical Guideline. Guideline for the child with possible arthritis (joint swelling/pain, loss of function)

Transcription:

Assessment of Inflammatory Back Pain: New Concepts in Diagnosis March 2 nd, 2018 Spine Therapy Network Interprofessional Synposium Sheraton Toronto Airport Hotel, Toronto, CANADA Laura Passalent PT, BScPT, MHSc, ACPAC Physiotherapist Practitioner, Arthritis Program, Toronto Western Hospital Clinician Investigator, Krembil Research Institute Lecturer, Department of Physical Therapy, University of Toronto

Disclosures I have received honoraria for participation on advisory boards and speaking engagements from: AbbVie Amgen Janssen Novarits

Case Study: History 32 yr old male 1.5 year Hx of alternating buttock pain (insidious onset); 60 min a.m. stiffness; pain/stiffness improve with activity; difficulty sleeping, both getting and staying asleep 3

Case Study: History Prior Rx: MT (temp relief); Ibuprofen 400mg BID (mod relief); Tylenol ES PRN (mod relief) PMHx: unremarkable FamHx: Sister with Crohn s disease 4

60-90% 5-10% Mechanical Back Pain Inflammatory Back Pain Axial Spondyloarthritis 1-2%

Axial Spondyloarthritis

Axial Spondyloarthritis Nonradiographic axial spondyloarthritis Ankylosing Spondylitis

Epidemiology ~1.5 % prevalence (SpA) - ~0.5 % (AS) Ages 15-40 HLA-B27 Axial (SI joint > spinal) versus peripheral joint disease Enthesitis Extra articular involvement

ANKYLOSING SPONDYLITIS

SpA cellular and molecular pathology genetic susceptibility inflammation SpA: cellular and molecular pathology destruction remodeling

NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS

Assessment of Axial Spondyloarthritis

Axial SpA Evaluation History Description of back pain (including Red Flags) Peripheral joint involvement EAMs, PMHx, FamHx, Meds, Social Hx Physical Exam Spinal mobility Peripheral Exam (tender/swollen joints, enthesitis, dactylitis, skin, nails) Investigations Radiographs (SIJ, L/S, C/S) Labs (HLA B27, CRP, ESR) +/- MRI

Axial SpA Evaluation History Description of back pain (including Red Flags) Peripheral joint involvement EAMs, PMHx, FamHx, Meds, Social Hx Physical Exam Spinal mobility Peripheral Exam (tender/swollen joints, enthesitis, dactylitis, skin, nails) Investigations Radiographs (SIJ, L/S, C/S) Labs (HLA B27, CRP, ESR) +/- MRI

HISTORY

IBP: independent contributors (Sieper J et al, 2009) Independent contributors Insidious onset (p=0.001) Pain at night (p=0.001) Age at onset <40yrs (p=0.004) Improvement with exercise/activity (p=0.001) No improvement with rest (p=0.006) I.-P.A.I.N

Key comparisons Clinical Feature Inflammatory back pain Mechanical back pain Age of onset* < 40 years Any age Type of onset Insidious Variable Chronicity > 3 months < 3 months Aggravating/relieving factors Better with exercise/activity Worse with rest Worse with movement/activity Better with rest Usually flexion or extension pattern of pain Morning stiffness >30 minutes < 30 minutes Night pain Often awakening in the second half of the night Variable

Case Study: History 32 yr old male 1.5 year Hx of alternating buttock pain (insidious onset); 60 min a.m. stiffness; pain/stiffness improve with activity; difficulty sleeping, both getting and staying asleep 35

HISTORY

Peripheral joint arthritis

Extra articular manifestations

Family History First or second degree relative with: Ankylosing spondylitis Inflammatory bowel disease Uveitis Psoriasis/ psoriatic arthritis

NSAIDs Good response (present/past)

Case Study: History Prior Rx: MT (temp relief); Ibuprofen 400mg BID (mod relief); Tylenol ES PRN (mod relief) PMHx: unremarkable FamHx: Sister with Crohn s disease 44

LABORATORY

Acute Phase Reactants Erythrocyte sedimentation rate C-reactive protein

HLA B27 ~ 8% prevalence in population ~ 90 % prevalence in AS

Case Study: Investigations ESR: 3mm/h CRP: < 3mg/L 48

Case Study: Investigations ESR: 3mm/h CRP: < 3mg/L HLA B27: present 49

IMAGING

Case Study: Imaging 51

Case Study: Imaging

Case Study: Imaging 53

Case Study: Diagnosis? Non-radiographic axial SpA 54

www.uhnspondylitis.ca

Laura Passalent PT, BScPT, MHSc, ACPAC Physiotherapist Practitioner Spondylitis Program Toronto Western Hospital laura.passalent@uhn.ca